Market Newsdesk

WALL, N.J., March 31, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of biometric authentication and security solutions, today announced it has fulfilled a pair of significant follow-on orders from a leading international defense ministry as part of a major expansion of their BIO-key deployment, initially reported in January of 2018.

After originally being referred to BIO-key by Microsoft’s Windows Core Security and Identity Management Team, the ministry’s technology team evaluated and selected WEB-key, BIO-key’s core biometric software engine, to integrate for strong authentication with Microsoft Windows Active Directory Federation Services (ADFS), delivering biometric single sign-on access control to secure shared files, Microsoft Office applications and Outlook. After successful initial deployment and operation, the ministry has placed multiple follow-on orders, including two in the last 90 days totaling nearly half a million dollars, adding more BIO-key software and hardware to provide secure access by thousands of additional users at thousands more workstations.

“We take particular pride in follow-on orders from our customers because it means we are helping them with their mission as it evolves,” stated Jim Sullivan, BIO-key Senior Vice President, Strategy, Compliance and Chief Legal Officer. “This particular customer is globally recognized for its cutting-edge cyber-security expertise. We were delighted that such a capable and prestigious technology team determined that BIO-key met their security and scalability requirements and have now made several follow-on investments to grow their BIO-key user base. The true test of a product is whether it works for customers after the first deployment so they become repeat customers.” added Sullivan.

About BIO-key International, Inc. (
www.bio-key.com
)

BIO-key streamlines secure connections between people and the applications they use to get things done. BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions. Its PortalGuard IAM solution provides convenient and secure access to devices, information, applications, and authorization for high-value transactions. BIO-key’s patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premise and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.

BIO-key Safe Harbor Statement

All statements contained in this press release other than statements of historical facts are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes,” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe harbor” provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.

Engage with BIO-key

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Media Contact

Erin Knapp
Matter Communications
[email protected]
914-260-3158

Investor Contacts
William Jones, David Collins
Catalyst IR
[email protected]
212-924-9800

 

MONTREAL, March 31, 2021 (GLOBE NEWSWIRE) — Dynacor Gold Mines Inc. (TSX: DNG / OTC: DNGDF) (Dynacor or the Corporation) released its audited annual consolidated financial statements and the management’s discussion and analysis (MD&A) for the year ended December 31, 2020.

These documents have been filed electronically with SEDAR at www.sedar.com and will be available on the Corporation’s website www.dynacor.com.

(All figures in this press release are in Ms of US$ unless stated otherwise. All amounts per share are in US$. All variance % are calculated from rounded figures. Some additions might be incorrect due to rounding).

2020 OVERVIEW AND HIGHLIGHTS

OVERVIEW

In an historical year marked by the Covid-19 pandemic and which continues to pose global challenges, Dynacor completed its fiscal 2020 recording its 10^th consecutive profitable year with a net income of $4.3 million compared to $5.2 million in 2019 and with a 9.3% increase in EBITDA to $11.7 million, including $4.8 million in Q4-2020 ($2,2 million in Q4-2019).

Dynacor started 2020 with a strong operational performance which was suddenly stopped by the Covid-19 pandemic. The three-month operation stoppage from March 16 till June 5, 2020, ended, in Q2-2020, a streak of thirty-six (36) consecutive profitable quarters. In Q3, the Corporation successfully resumed its ore purchase and processing activities, immediately returning to profit, and strongly ended 2020.

The Corporation was able to retain all of its ore suppliers and to steadily increase its ore purchasing and processing levels ending 2020 with an ore inventory exceeding 8,000 tonnes which represents 24 days of production, ready to face the usual first quarter rainy season.

Total sales for the year amounted to $101.5 million compared to $102.5 million.

The resumption of activities, together with the return of employees and suppliers, was in full compliance with the Ministry of Health guidelines. Our Covid-19 sanitary protocol contains measures to monitor the risk of exposure to the Covid-19 at our workplaces, as well as establishing prevention and control standards to avoid the appearance and/or the spread of the virus and to ensure the health and safety of our workers, suppliers, customers and visitors.

HIGHLIGHTS

Operational

• High daily volume processed. Overall, in 2020 given the temporary shut-down due to the Covid-19 crisis, the Veta Dorada plant processed a volume of 77,978 tonnes of ore (274 tpd) compared to 98,649 (270 tpd) in 2019 (Considering 285 potential working days due to Covid-19 restrictions plant shut-down in 2020 and 365 days for 2019); 
• Dynacor completed 2020 with a quarter-to-quarter production increase of 63.4%. During Q4-2020, gold equivalent production amounted to 22,263 AuEq ounces compared to 13,629 AuEq ounces in Q3-2020. Overall, in 2020, the Corporation produced 51,369 AuEq ounces compared to 82,216 AuEq ounces in 2019; 
• High level of ore inventory. With an all-time quarterly best ore purchase volume of 34,110 tonnes in Q4-2020, the Corporation completed 2020 with a level of inventory exceeding 8,000 tonnes which allowed the Chala plant to run at full production capacity during the first quarter of 2021 and annual rainy season.

Financial

• 10^th consecutive year of profits. Despite Covid-19 and a $1.2 million deferred income tax charge, Dynacor recorded a net income of $4.3 million in 2020 ($0.11 or CA$0.15 per share) compared to $5.2 million ($0.13 or CA$0.17 per share) in 2019;
• Sales comparable to 2019 despite decreased gold production. Thanks to a significantly higher gold market price in 2020, sales amounted to $101.5 million in 2020 compared with $102.5 million in 2019;
• Increased gross operating margin. Gross operating margin of $13.6 million in 2020, an increase of 4.6% compared to $13.0 million in 2019;
• Increased operating income. Operating income of $9.5 million compared to $8.5 million in 2019, a 14.4% increase.
• Higher cash gross operating margin. Cash gross operating margin of $276 per AuEq ounce sold ⁽¹⁾ compared to $208 in 2019;
• Increased EBITDA. EBITDA ⁽²⁾ of $11.7 million (including $4.8 million in Q4-2020), an increase of 9.3% compared to 2019;
• Robust cash-flow from operating activities before change in working capital items. Cash flow from operating activities before change in working capital items of $8.6 million ($0.21 per share) ⁽³⁾ similar to 2019;
• Solid cash position. Cash on hand of $11.9 million at year-end 2020 compared to a net cash position of $3.7 million in 2019.

Cash Return to Shareholders

• Increased dividends. 2020 quarterly dividends paid increased by 50% to CA$0.015 per share and totaling $1.7 million (CA$2.3 million).
• Change in dividend policy. Starting in February 2021, a CA$0.005 monthly dividend per share is paid replacing the CA$0.015 quarterly dividend. During 2020, dividends paid produced an average yield of 3.36%.

⁽¹⁾
Cash gross operating margin per AuEq ounce is in US$ and is calculated by subtracting the average cash cost of sale per equivalent ounces of Au from the average selling price per equivalent ounces of Au and is a non-IFRS financial performance measure with no standard definition under IFRS. It is therefore possible that this measure could not be comparable with a similar measure of another company.

⁽²⁾ EBITDA: “Earnings before interest, taxes and depreciation” is a non-IFRS financial performance measure with no standard definition under IFRS. It is therefore possible that this measure could not be comparable with a similar measure of another corporation. The Corporation uses this non-IFRS measure as an indicator of the cash generated by the operations and allows investor to compare the profitability of the Corporation with others by canceling effects of different assets bases, effects due to different tax structures as well as the effects of different capital structures.

⁽³⁾ Cash-flow per share is a non-IFRS financial performance measure with no standard definition under IFRS. It is therefore possible that this measure could not be comparable with a similar measure of another corporation. The Corporation uses this non-IFRS measure which can also be helpful to investors as it provides a result which can be compared with the Corporation market share price.

RESULTS FROM OPERATIONS

Extract from Audited Consolidated Statement of net income and comprehensive income

	For the years ended December 31,
(in $’000)	2020	2019
Sales	101,533	102,499
Cost of sales	(87,928 )	(89,531)
Gross operating margin	13,605	12,968
General and administrative expenses	(3,944 )	(4,497)
Other projects	(145 )	(155)
Operating income	9,516	8,316
Income before income taxes	8,958	8,120
Current income tax expense	(3,427 )	(2,962)
Deferred income tax expense,	(1,196 )	29
Net income and comprehensive income	4,335	5,187
Earnings per share
Basic	$ 0.11	$0.13
Diluted	$ 0.11	$0.13

Total sales for the year 2020 were similar to last year. The average gold market price was at $1,770/oz vs. $1,393/oz in 2019 which had a positive effect on sales.

The gross operating margin amounted to $13.6 million in 2020 compared to $13.0 million in 2019. The 2020 gross operating margin beneficiated as well, from the margin derived from the December 2019 postponed export.

The gross operating margin includes underactivity fixed expenses incurred in Q2-2020 related to the closure of the plant as per the measures to prevent Covid-19 and amounting to approximately $1.2 million including mostly salaries of $0.7 million, as all employees were maintained in preparation for the restart of operations, and depreciation of $0.5 million.

General and administrative expenses amounted to $3.9 million in 2020, a 12.3% decrease compared to 2019 mainly due to non-recurring government grants applied against salaries expenses, a decrease in travel expenses and to the absence of provision for impairment of accounts receivable in 2020.

The 2020 net income was significantly impacted by a deferred income tax expense resulting from FX variances between the $US and the Peruvian Sol. Under IFRS, a deferred income tax effect must be recognized when an entity has a functional currency different from the currency used to determine its current taxes. Given the significant fluctuations between the $US and the Peruvian Sol in 2020 the Corporation recorded in Q4-2020 a $1.3 million deferred income tax expense and liability negatively impacting the 2020 tax rate, net income and income per share but had no cash impact for the Corporation in 2020.

Reconciliation of non-IFRS measures

(in $’000)	For the years ended December 31,
	2020	2019
Reconciliation of net income and comprehensive income to EBITDA
Net income and comprehensive income	4,335	5,187
Income taxes expense (current and deferred)	4,624	2,933
Financial expenses	178	60
Depreciation	2,514	2,551
EBITDA	11,651	10,731

CASH FLOW FROM OPERATING, INVESTING AND FINANCING ACTIVITIES AND 
WORKING CAPITAL AND LIQUIDITY

Operating activities

For the year ended December 31, 2020, the cash flow from operations, before changes in working capital items, amounted to $8.6 million, similar to the year ended December 31, 2019. Net cash from operating activities amounted to $11.2 million compared to (-$5.9 million) for the year ended December 31, 2019. Changes in working capital items amounted to $2.7 million compared to (-$14.3 million) for the year ended December 31, 2019.

Investing activities

During the year ended December 31, 2020, the Corporation invested $0.7 million ($1.2 million for the year ended December 31, 2019). This amount is mainly comprised of new vehicles and investments at the plant notably in relation with new health and safety protocols consequence of the Covid-19 crisis.

Additions to exploration and evaluation assets were limited to the maintaining and safekeeping of assets in 2020 and 2019.

Financing activities

In 2020, four quarterly dividends of CA$0.015 per share were disbursed for a total consideration of $1.7 million (CA$ 2.3 million). In 2019, four quarterly dividends of CA$0.01 per share were disbursed for a total consideration of $1.2 million (CA$ 1.6 million).

In 2020, the Corporation made repayments of lease liabilities of $0.6 million ($0.7 million in 2019).

In 2020, 149,185 common shares were repurchased under the Corporation normal course issuer bid share buyback program for a total cash consideration of $0.2 million or CA$ 0.3 million (847,721 shares for a total cash consideration of $1.1 million or CA$1.5 million in 2019).

Working Capital and Liquidity

As at December 31, 2020, the Corporation’s working capital amounted to $25.4 million, including $11.9 million in cash ($19.6 million, including $6.7 million in cash and $3.0 million in short-term loan at December 31, 2019).

EXTRACT FROM CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at December 31, 2020, total assets amounted to $76.3 million ($74.8 million as at December 31, 2019). Major variances since last year-end comes from the repayment of the short-term bank loan, increase in accounts receivable (all of those were fully collected after year-end), decrease in inventories due to the timing of our year-end gold export and the impact of the deferred tax liability recorded in Q4-2020.

	As at  December 31,	As at December 31,
(in $’000)	2020	2019
Cash	11,868	6,743
Accounts receivable	8,434	4,729
Inventories	13,401	18,301
Property, plant and equipment	19,677	20,959
Right-of-use assets	834	1,561
Exploration and evaluation assets	18,510	18,738
Other assets	3,572	3,782
Total assets	76,296	74,813
Trade and other payables	7,082	6,344
Bank loan	–	3,000
Asset retirement obligations	3,604	3,769
Current tax liabilities	1,124	419
Deferred tax liabilities	1,036	–
Lease liabilities	706	1,329
Shareholders’ equity	62,744	59,952
Total liabilities and equity	76,296	74,813

OUTLOOK 2021

Ore processing

Since the beginning of 2021 and despite the rainy season, the Corporation purchased monthly record highs of 9,931 tonnes and 11,248 tonnes for January and February, and the Chala plant has been operating at its full capacity. Given the volume of ore purchased, the Corporation was able to even increase its ore inventory during Q1-2021.

With this level of inventory and current strong ore purchases, the Corporation has initiated the expansion project at its Chala plant which will permit increasing the throughput level from its actual 343 tpd to 430 tpd, an increase of 25.0%.

Exploration

The Corporation has planned a drilling program on the Tumipampa project. This program will begin upon reaching a work agreement with local communities with an approximate budget of $1.0 million for 2021.

ABOUT DYNACOR

Dynacor is a dividend-paying industrial gold ore processor headquartered in Montreal, Canada. The corporation is engaged in gold production through the processing of ore purchased from the ASM (artisanal and small-scale mining) industry. At present, Dynacor operates in Peru, where its management and processing teams have decades of experience working with ASM miners. It also owns a gold exploration property (Tumipampa) in the Apurimac department.

The corporation intends to expand its processing operations in other jurisdictions as well.

Dynacor produces environmental and socially responsible gold through its PX IMPACT® gold program. A growing number of supportive firms from the fine luxury jewelry, watchmakers and investment sectors pay a small premium to our customer and strategic partner for this PX IMPACT® gold. The premium provides direct investment to develop health and education projects for our artisanal and small-scale miner’s communities.

Dynacor is listed on the Toronto Stock Exchange (DNG) and the OTC in the United States under the symbol (DNGDF).

FORWARD-LOOKING INFORMATION

Certain statements in the preceding may constitute forward-looking statements, which involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Dynacor, or industry results, to be materially different from any future result, performance or achievement expressed or implied by such forward-looking statements. These statements reflect management’s current expectations regarding future events and operating performance as of the date of this news release.
Toronto Stock Exchange (TSX): DNG
OTC (United States): DNGDF

Shares Outstanding: 38 815 029

Website: http://www.dynacor.com
Twitter: http://twitter.com/DynacorGold 

PDF available: http://ml.globenewswire.com/Resource/Download/c4577990-f35c-4608-b497-a51981f01d3c 

CONTACT: For more information, please contact:

Director, Shareholder Relations
Dale Nejmeldeen
Dynacor Gold Mines Inc.
T: 514-393-9000 #230
E: [email protected]

Voting Rights and Capital

In conformity with the Disclosure Guidance and Transparency Rules, we hereby notify the market of the following:

Royal Dutch Shell plc’s capital as at March 31, 2021, consists of 4,101,239,499 A shares and 3,706,183,836 B shares, each with equal voting rights. Royal Dutch Shell plc holds no ordinary shares in Treasury.

The total number of A shares and B shares in issue as at March 31, 2021 is 7,807,423,335 and this figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Royal Dutch Shell plc under the FCA’s Disclosure Guidance and Transparency Rules.

Enquiries
Shell Media Relations
International, UK, European Press: +44 (0)207 934 5550

LEI number of Royal Dutch Shell plc:  21380068P1DRHMJ8KU70
Classification: Total number of voting rights and capital

 

NASHVILLE, Tenn., March 31, 2021 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, announced today its plan to continue the Company’s international expansion with a launch in Mexico. The first two SmileShop locations will open in April in Mexico City. This marks the Company’s entrance into Latin America as it pursues the massive global market opportunity for its innovative, premium, affordable telehealth solution for orthodontia.

“SmileDirectClub is the global leader and innovator of clear aligner therapy through telehealth and trusted by well over a million customers who have achieved a smile they love with our product,” said Kay Oswald, President of International at SmileDirectClub. “We’re bringing our premium, safe, and effective orthodontia solution to Mexico to give consumers in Latin America a more affordable and convenient option to straighten their teeth.”

According to the Company’s research, approximately 80% of Mexicans believe they’d benefit from teeth straightening but the majority are prevented from pursuing it due to the cost and inconvenience of traditional orthodontics. Priced at 40% less than other options in the local market, SmileDirectClub exists to bridge that gap.

Customers seeking clear aligner therapy using the SmileDirectClub telehealth platform may book a free appointment at a SmileShop to capture a 3D image of their teeth. Clear aligner therapy with SmileDirectClub is prescribed, directed, and managed by an affiliated and locally registered dentist or orthodontist throughout the entire process from initial diagnosis to completion.

Since launching in the U.S. in 2014, SmileDirectClub has become one of the fastest-growing health technology companies and continues to be the leading telehealth platform for orthodontia. SmileDirectClub has straightened smiles for well over one million customers in 13 markets around the world – the largest international footprint of any company providing clear aligner therapy through telehealth.

About SmileDirectClub

SmileDirectClub, Inc. (Nasdaq: SDC) (“SmileDirectClub”) is an oral care company and creator of the first medtech platform for teeth straightening, now also offered directly via dentist and orthodontist offices. Through its proprietary technology and vertically integrated model, SmileDirectClub is revolutionizing the oral care industry, offering consumers the ability to get clinically safe and effective treatment but without the 3x markup associated with traditional orthodontics. SmileDirectClub’s mission is to democratize access to a smile each and every person loves by making it affordable and convenient for everyone, from clear aligner therapy to premium oral care products. SmileDirectClub is headquartered in Nashville, Tennessee and operates in the U.S., Canada, Australia, New Zealand, United Kingdom, Ireland, Germany, Austria, Spain, Netherlands, Hong Kong, Singapore and Mexico. For more information, please visit SmileDirectClub.com.

Contact:

SmileDirectClub Media Relations: [email protected]

BOWIE, Md., March 31, 2021 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced new research to be presented across all major healthcare coverage populations powered by its large-scale, real-world Medical Outcomes Research for Effectiveness and Economics Registry (MORE² Registry^®).

Inovalon’s MORE² Registry^®, one of the nation’s largest and most comprehensive healthcare datasets, will be featured in research presented at: the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting, the American Thoracic Society (ATS) International Conference, the American College of Cardiology’s 70th Annual Scientific Session, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Digestive Disease Week 2021, and the AcademyHealth Annual Research Meeting.

“The research that is being presented at these conferences showcases the capabilities and depth of the MORE² Registry^®,” said John E. Linnehan, practice director of Health Economics & Advanced Analytics in Inovalon’s Life Sciences & Advisory Services business. “The MORE² Registry^® provides an unparalleled view of the healthcare marketplace, giving all healthcare stakeholders practical solutions to understand, influence, and thrive in today’s environment.”

Inovalon’s MORE² Registry^® dataset is one of the nation’s largest primary source, longitudinally matched datasets containing real-world medical, pharmacy, laboratory, demographic, and clinical data on more than 332 million unique patients and 61 billion medical events across Medicare fee-for-service, Medicare Part D, Medicare Advantage, managed Medicaid, and commercially insured populations. Ongoing analysis of the MORE² Registry^® dataset powers highly valuable insights into important healthcare issues; machine learning, deep learning, and artificial intelligence algorithm development and training for Modules of the Inovalon ONE^® Platform; and the real-time decision support, care, quality, outcomes and economic improvements of healthcare empowered through Inovalon’s solutions.

This research, spanning multiple high-impact healthcare industry challenges, was conducted by Avalere Health, an Inovalon company specializing in data-driven healthcare research and strategic advisory services, in partnership with its clients.

Research to be Presented

AMCP Managed Care & Specialty Pharmacy Annual Meeting from April 13-14, 2021

• Mortality, Healthcare Burden and Costs of Clostridioides Difficile Infections and Recurrences in the Medicare Population
• Relationship of COPD Exacerbation Burden on Subsequent Healthcare Costs in a Medicare FFS Claims Analysis
• Direct Healthcare Resource Utilization and Cost in Managed Care Members with Non-Dialysis Dependent Chronic Kidney Disease, with and Without Severe Anemia
• Real-World Healthcare Utilization, Costs, and Overall Survival Among Patients with Intermediate- to High-Risk Myelofibrosis in the United States: Ruxolitinib Exposed vs. Unexposed

ATS International Conference from May 14-19, 2021

• Does Baseline Exacerbation History in COPD Predict Future Exacerbation Frequency? Real-World Insights from Multiple U.S. Insurers
• Pneumonia Burden and Exacerbations: A Large Real-World Evaluation of Events and Risks Among COPD Patients in the U.S.

American College of Cardiology’s 70th Annual Scientific Session from May 15-17, 2021

• Part D Out of Pocket Payments in Medicare Beneficiaries with Heart Failure with Reduced Ejection Fraction

Virtual ISPOR 2021 from May 15-17, 2021

• Healthcare Utilization, Cost, and Quality Among High-Need, High-Cost Medicare Beneficiaries in Medicare Fee-for-Service vs. Medicare Advantage
• Incident Costs of Dialysis Initiation Among Medicare Beneficiaries with Advanced Chronic Kidney Disease
• Characteristics, Cost, and Healthcare Resource Use in a Population of Medicare Fee-for-Service Patients with Chronic Obstructive Pulmonary Disease (COPD) Who also Experience Pneumonia

Digestive Disease Week 2021 from May 21-23, 2021

• A Real-World Comparison of Mortality, Healthcare Resource Utilization, and Cost Among Medicare Beneficiaries with Clostridioides Difficile Infection with and Without Sepsis

AcademyHealth Annual Research Meeting from June 14-17, 2021

• Healthcare Utilization, Cost and Quality Among High-Need Medicare Beneficiaries in Medicare Fee-for-Service vs. Medicare Advantage

About Inovalon

Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE^® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action^®.” Supporting thousands of clients, including all 25 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than one million physicians, 574,000 clinical facilities, 332 million Americans, and 61 billion medical events. For more information, visit www.inovalon.com.

Contact:

Kim E. Collins
Senior Vice President, Corporate Communications
[email protected]
301-809-4000 x1473

Hulus Alpay
Vice President, Investor Relations
[email protected]
301-809-4000 x1237

MACAU, March 31, 2021 (GLOBE NEWSWIRE) — Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2020. The annual report can be accessed under the Annual Reports section on the Company’s investor relations website at https://ir.studiocity-macau.com/annual-reports.

The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests can be made through the Information Request section on the Company’s investor relations website at https://ir.studiocity-macau.com/document-request.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Studio City International Holdings Limited (the “Company”) may also make forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to, (i) the global pandemic of COVID-19, caused by a novel strain of the coronavirus, and the continued impact of its consequences on our business, our industry and the global economy, (ii) growth of the gaming market and visitations in Macau, (iii) capital and credit market volatility, (iv) local and global economic conditions, (v) our anticipated growth strategies, (vi) gaming authority and other governmental approvals and regulations, and (vii) our future business development, results of operations and financial condition. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “anticipate”, “target”, “aim”, “estimate”, “intend”, “plan”, “believe”, “potential”, “continue”, “is/are likely to” or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company undertakes no duty to update such information, except as required under applicable law.

About Studio City International Holdings Limited

The Company, with its American depositary shares listed on the New York Stock Exchange (NYSE: MSC), is a world-class integrated resort located in Cotai, Macau. For more information about the Company, please visit www.studiocity-macau.com.

The Company is strongly supported by its single largest shareholder, Melco Resorts & Entertainment Limited, a company with its American depositary shares listed on the NASDAQ Global Select Market (NASDAQ: MLCO). 

For investment community, please contact:

Timothy Mazik
Tel: +852 2598 3516
Email: [email protected]

For media enquiries, please contact:

Chimmy Leung
Executive Director, Corporate Communications
Tel: +852 3151 3765
Email: [email protected]